A commitment to access and affordability
99% of Medicare and Medicaid patients are COVERED for COBENFY*
9 out of 10 patients paid $0 out of pocket for COBENFY†
Find your local coverage
Now that you may have found your local coverage, did you know?
90% of claims were approved‡
Partner with our Patient Access Liaison (PAL) team for access support
Our team of Patient Access Liaisons (PALs) are local and dedicated professionals who can support you with navigating your patient’s access to COBENFY. Request a PAL through our Chatbot.
Patient Access Liaisons
Navigate the path to insurance coverage for COBENFY
Support access for COBENFY
Prior authorization support for COBENFY
Access and coverage support for patients
Coverage and access resources
Prior Authorization and Appeals Guide
Provides information about the COBENFY prior authorization and appeal processes for practices.
Letter of Authorization Template
Use this template to write a letter to authorize treatment with COBENFY, which payers may require prior to filling a prescription.
Letter of Medical Necessity Template
Use this template to write a letter to establish medical necessity for COBENFY, which payers may require prior to filling a prescription.
For you and your staff
Patient Access Liaisons (PALs)
Our team of Patient Access Liaisons (PALs) are local and dedicated professionals who can navigate patient access.
COBENFY Cares™/Patient Access Liaisons Summary Flashcard
Communicates key COBENFY Cares program details to HCPs and staff, including the roles of COBENFY Cares Champions* and Patient Access Liaisons.
| * | COBENFY Cares Champions are available to provide support to patients who have been prescribed COBENFY. Champions do not provide medical advice or care. COBENFY Cares Champions are provided as a service by Bristol Myers Squibb. Patients should discuss any questions about their medical conditions and treatment options with their healthcare providers. |
Prior Authorization Support for COBENFY
By automating part of the process providers and pharmacists use for prior authorization (PA) requests, CoverMyMeds helps patients access their medications faster (compared to phone and fax).
CoverMyMeds: Automating Part of the Prior Authorization (PA) Process
Prior authorization support is available when COBENFY is prescribed.
For your patients
COBENFY Co-Pay Assistance Program*
Patients with commercial insurance may be eligible to pay as little as $0 per month.
| * | Eligibility and Terms and Conditions apply. See the COBENFY Co-Pay Assistance Program terms and conditions for details. |
Medicaid and Medicare Part D/Low Income Subsidy Brochure
A resource providing an overview of Medicare and Medicaid coverage for COBENFY.
| * | Formulary data are provided by Fingertip Formulary Data and are current as of 04/26. Because formularies change and many payers offer more than one formulary, please check directly with the payer to confirm coverage requirements and status for individual patients. Coverage and benefits are subject to change without notice. The accurate completion of reimbursement or cover-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item. Bristol Myers Squibb does not endorse any individual health plans. |
| † | Out-of-pocket distribution data cost averages are provided by IQVIA FIA and include prescriptions filled among Commercial, Medicare, and Medicaid patients, latest 4 weeks ending 12/26/25, and reflect any financial assistance that was used. “Commercially Insured Patients” is inclusive of commercially insured patients eligible and receiving assistance through the Co-Pay Assistance Program. “Medicare and Medicaid Patients” are not eligible for the Co-Pay Assistance Program, but may be eligible for other forms of third-party co-pay assistance. Some patients may pay more than the cost listed above. |
| ‡ | Claims approval data are provided by IQVIA FIA and include prescriptions among Commercial, Medicare, and Medicaid patients, latest 8 weeks ending 01/23/26. |
| Please note that plans may have multiple formularies, and they are subject to change by the plan. | |
| Please check with the health plan directly to confirm formulary status, requirements, and coverage information for individual patients. | |
| Source: Fingertip Formulary database as of 08/15/2025. | |
| This information is intended only to show formulary coverage status for each product and should not be construed to make any comparisons of safety, efficacy, or other clinical outcomes. The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any services or item. Bristol Myers Squibb does not endorse any individual health plan. |
References:
- Announcement of calendar year (CY) 2026 Medicare Advantage (MA) capitation rates and Part C and Part D payment policies. Centers for Medicare and Medicaid Services. April 7, 2025. Accessed January 16, 2026. https://www.cms.gov/files/document/2026-announcement.pdf